Leukodystrophies in Children: Diagnosis, Care, and Treatment

Area of Science:

• Neurology
• Genetics
• Pediatrics

Background:

• Leukodystrophies are inherited disorders impacting myelin development and maintenance in the central nervous system.
• These conditions affect at least 1 in 4700 live births, leading to significant morbidity and increased mortality.
• Presentation varies widely, occurring from infancy to adulthood with symptoms like developmental delay, seizures, and spasticity.

Purpose of the Study:

• To provide a comprehensive overview of leukodystrophies.
• To discuss their types, prevalence, clinical manifestations, diagnostic approaches, and therapeutic strategies.
• To highlight the importance of understanding these disorders for healthcare providers.

Main Methods:

• Review of existing literature on leukodystrophies.
• Discussion of diagnostic criteria, including clinical evaluation, imaging, and genetic testing.
• Analysis of current and emerging treatment options.

Main Results:

• Leukodystrophies encompass diverse genetic conditions affecting CNS myelin.
• Diagnosis relies on a multi-faceted approach combining clinical, radiological, and genetic data.
• While cures are limited, advancements in care significantly improve patient well-being.

Conclusions:

• Understanding leukodystrophies is essential for pediatricians and healthcare providers.
• Advances in diagnostics and the need for timely treatments underscore the importance of early identification.
• Newborn screening for leukodystrophy is becoming increasingly vital for early intervention.